| 股號 / 名稱 | 營收 | 稅後淨利 |
| 1795 美時 | 7,365,334,000 | -107,989,000 |
| 6472 保瑞 | 6,452,777,000 | 653,706,000 |
| 4114 健喬 | 2,248,347,000 | 140,544,000 |
| 3705 永信 | 2,011,603,000 | 273,158,000 |
| 4105 東洋 | 1,974,390,000 | 577,415,000 |
| 1720 生達 | 1,920,007,000 | 402,136,000 |
| 4120 友華 | 1,191,203,000 | -65,511,000 |
| 1734 杏輝 | 849,611,000 | 67,337,000 |
| 3176 基亞 | 680,772,000 | 81,895,000 |
| 1752 南光 | 503,075,000 | 29,067,000 |
| 6589 台康生技 | 492,812,000 | 6,088,000 |
| 1760 寶齡富錦 | 491,637,000 | 25,344,000 |
| 6547 高端疫苗 | 490,942,000 | 109,249,000 |
| 4123 晟德 | 481,029,000 | 12,131,000 |
| 4128 中天 | 456,710,000 | -337,565,000 |
| 4166 友霖 | 396,581,000 | 76,629,000 |
| 4111 濟生 | 354,720,000 | 42,269,000 |
| 4167 松瑞藥 | 318,743,000 | -98,931,000 |
| 1799 易威 | 313,914,000 | 16,533,000 |
| 4726 永昕 | 308,195,000 | -41,941,000 |
| 6496 科懋 | 230,114,000 | -33,234,000 |
| 6620 漢達 | 208,799,000 | 16,877,000 |
| 1786 科妍 | 202,671,000 | 23,034,000 |
| 3118 進階 | 186,057,000 | 15,375,000 |
| 4127 天良 | 170,649,000 | -26,746,000 |
| 4747 強生* | 149,249,000 | -52,745,000 |
| 3205 佰研 | 102,424,000 | -8,022,000 |
| 6661 威健生技 | 100,965,000 | -3,262,000 |
| 6662 樂斯科 | 71,742,000 | 11,873,000 |
| 6576 逸達 | 63,275,000 | -148,328,000 |
| 4108 懷特 | 36,421,000 | -1,009,000 |
| 4743 合一 | 20,240,000 | -281,589,000 |
| 4157 太景*-KY | 433,905,663.83 | -530,288,843.05 |
| 6461 益得 | 13,072,000 | -136,620,000 |
| 6617 共信-KY | 11,773,000 | -21,779,000 |
| 6550 北極星藥業-KY | 7,317,000 | -449,124,000 |
| 6875 國邑* | 4,801,000 | -118,123,000 |
| 4168 醣聯 | 1,148,000 | -56,688,000 |
| 6785 昱展新藥 | 0 | -11,192,000 |
| 6838 台新藥 | 0 | -103,161,000 |
載入數據中...